Lobe Sciences Ltd (LOBEF OTCQB) stock market data APIs
$0.048
0(0%)
as of October 1, 2026
Try our APIs with
free plan!
Lobe Sciences Ltd Financial Data Overview
Price chart is built with
Anychart
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada.
Prev. Close
0.048
Open
0.048
High
0.048
Low
0.048
52 wk Range
0.0021-0.094
Market Cap
11 865 K
Shares Outstanding
308 M
EPS
-0.0014
Beta
-0.014
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Lobe Sciences Ltd data using free add-ons & libraries
Get Lobe Sciences Ltd Fundamental Data
Lobe Sciences Ltd Fundamental data includes:
- Net Revenue:
- EBITDA: -4 091 613
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Lobe Sciences Ltd News
New
Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
● Dr. Frederick D. Sancilio to present "Reimagining Psychedelic Therapeutics for Daily Outpatient Use: Advancing Low-Dose Psilocin Beyond the Hallucinogenic Paradigm" on Wednesday, September 16 ●...
Lobe Sciences reports Q3 results
* Lobe Sciences Ltd. press release [https://seekingalpha.com/pr/20621997-lobe-sciences-reports-third-quarter-2026-financial-results] (LOBEF [https://seekingalpha.com/symbol/LOBEF]): Q3 Net loss: $4...
Lobe Sciences launches non-brokered private placement of 14.62M shares at $0.065
Lobe Sciences (LOBEF [https://seekingalpha.com/symbol/LOBEF]) has announced a non-brokered private placement [https://seekingalpha.com/pr/20469672-lobe-sciences-ltd-announces-non-brokered-private-plac...
Lobe Sciences names Mirza Rahimani as CFO; succeeds Yong Yao
Lobe Sciences (LOBEF [https://seekingalpha.com/symbol/LOBEF]) announced that Mirza Rahimani has been promoted to CFO [https://seekingalpha.com/pr/20428292-lobe-sciences-announces-appointment-of-mr-mir...
Get Lobe Sciences Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.